Literature DB >> 1363378

GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS.

S Agrawal, J Y Tang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1363378     DOI: 10.1089/ard.1992.2.261

Source DB:  PubMed          Journal:  Antisense Res Dev        ISSN: 1050-5261


× No keyword cloud information.
  22 in total

1.  Construction and selection of bead-bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing.

Authors:  Xianbin Yang; Suzanne E Bassett; Xin Li; Bruce A Luxon; Norbert K Herzog; Robert E Shope; Judy Aronson; Tarl W Prow; James F Leary; Romy Kirby; Andrew D Ellington; David G Gorenstein
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

Review 2.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

Review 3.  Gene therapy for infectious diseases.

Authors:  B A Bunnell; R A Morgan
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  A general purpose RNA-cleaving DNA enzyme.

Authors:  S W Santoro; G F Joyce
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

5.  Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.

Authors:  J Lisziewicz; D Sun; V Metelev; P Zamecnik; R C Gallo; S Agrawal
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

6.  Triplex-forming oligonucleotides trigger conformation changes of a target hairpin sequence.

Authors:  E Brossalina; E Demchenko; Y Demchenko; V Vlassov; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

7.  DNA as therapeutics; an update.

Authors:  P Saraswat; R R Soni; A Bhandari; B P Nagori
Journal:  Indian J Pharm Sci       Date:  2009-09       Impact factor: 0.975

8.  Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity.

Authors:  J Y Tang; J Temsamani; S Agrawal
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

Review 9.  Pharmacokinetics of antisense oligonucleotides.

Authors:  S Agrawal; J Temsamani; W Galbraith; J Tang
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

Review 10.  Prospects for antisense peptide nucleic acid (PNA) therapies for HIV.

Authors:  Virendra N Pandey; Alok Upadhyay; Binay Chaubey
Journal:  Expert Opin Biol Ther       Date:  2009-08       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.